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Abstract 
Precision medicine requires the precision disease risk prediction models. In literature, there have been a lot well-
established (inter-)national risk models, but when applying them into the local population, the prediction performance 
becomes unsatisfactory. To address the localization issue, this paper exploits the way to develop knowledge-enhanced 
localized risk models. On the one hand, we tune models by learning from regional Electronic Health Record (EHR) 
repositories, and on the other hand, we propose knowledge injection into the EHR data learning process. For 
experiments, we leverage the Pooled Cohort Equations (PCE, as recommended in ACC/AHA guidelines to estimate 
the risk of ASCVD) to develop a localized ASCVD risk prediction model in diabetes. The experimental results show 
that, if directly using the PCE algorithm on our cohort, the AUC is only 0.653, while our knowledge-enhanced 
localized risk model can achieve higher prediction performance with AUC of 0.723 (improved by 10.7%). 
Introduction 
Generally, development of a chronic disease risk prediction model needs years of studies, and a famous example is 
the Framingham Heart Study, which began in 1948 and is now on its third generation of participants1. Such high-
quality evidence is undoubtedly expected to be guidance for applications in clinical decision support. However, when 
applying those (inter-)national risk models to a localized population, e.g. at a tier II city in China, the prediction 
performance is not satisfactory. Well, is it possible to develop a localized chronic disease risk prediction model for 
each regional population (e.g. as of June 2016, China has 662 cities)?   
To address this problem, it requires two important keys. First is the data, and for traditional clinical research, the data 
consists of long-term follow-up questionnaires. We cannot expect to call for participants in each regional population, 
but thanks to development of regional health information systems in China, Electronic Health Record (EHR) 
repositories have been growing up with a great amount of longitudinal patient visits2. Thus, the above question is now 
decomposed into two, and the first sub-question is: (1) Does an EHR repository has the equal data quality for 
developing a chronic disease risk prediction model? We realize this sub-question has been positively answered in 
related work3,4,5, but frankly, when exploring the EHR data of a developing country, e.g. China, we have more data 
quality issues, and we will systematically present the problems and possible solutions in this paper. 
Then is the technique, and in literature, either traditional clinical research algorithms (such as logistic regression and 
cox regression), or advanced machine learning algorithms (such as neural networks and reinforcement learning), have 
more or less proven their prediction power3,4,5. However, there is few work on the localization of (inter-)national 
chronic disease risk prediction models, by deep learning from regional EHR repositories. Those well-established 
models are often treated as the competitors (e.g. for the baseline), but not the cooperators. In this paper, we are not 
going to reinvent the wheels, and instead, we are trying to answer the second sub-question: (2) How to develop a 
localized chronic disease risk prediction model by injecting domain knowledge into the EHR data learning process? 
Actually, the idea of knowledge combination with learning is not novel, and in a high level perspective, the field of 
artificial intelligence itself is a combination of knowledge representation/reasoning and machine learning/inference. 
Interest in this combination could trace back to the 1990s, and one of the representatives was the Knowledge-based 
Artificial Neural Networks (KBANN)6, mapping propositional logic into neural networks. Later, Markov Logic 
Networks (MLN)7 were proposed, combining first-order logic and probabilistic graphical models. For applications, 
the work of Fold.all demonstrated its improved performance in topic discovery from movie reviews and PubMed 
abstracts8. Another recent work of teacher-student networks presented its success on a knowledge-harnessed 
convolutional neural network for sentiment analysis, and a knowledge-harnessed recurrent neural network for named 
entity recognition9. More interestingly, even physics knowledge, such as Kinematic equations and free fall, haven 
been used to supervising neural networks10. However, in healthcare domain, the knowledge learning symbiosis still 
needs to exploit its way. Particularly, we observe different knowledge types in clinical problems, e.g. logical rules 
(like if-then) for treatment recommendations, arithmetic formulas (like logistic regression and cox regression) for risk 
prediction, knowledge graph (like SNOMED ontology) for feature correlation. Besides, there are different knowledge 
  
injection methods, and in terms of learning process, we roughly category them into three types (which formal 
definitions will be presented in the section of model learning): (1) knowledge injection to input features, (2) knowledge 
injection to objective functions, (3) knowledge injection to output labels. For the first injection type, a straightforward 
implementation is to add knowledge-based features, e.g. those well-known risk factors and/or the calculated risk scores 
in a disease risk model. For the second injection type, most related work used logic constraints as regularization terms 
in the learning objective function, when training neural networks (e.g. the teacher-student networks9) or probabilistic 
graphical models (e.g. the Fold.all framework8). The latest work directly specifies the knowledge constraints as 
objective functions, without direct examples of input-output pairs10. For the third injection type, it could be a decision 
fusion of knowledge-generated labels and data-generated labels11, and such decision fusion could be majority voting, 
weighted average, meta-classification, etc. In this paper, we focus on the risk models as our knowledge type, and 
implement all of the three knowledge injection methods, where our knowledge-enhanced neural networks (KENN)12 
is one of the implementations for knowledge injection to objective functions. 
For experiments, we start from a raw regional EHR repository, and by relational association with patient IDs and 
encounter IDs, we construct a cohort for predicting Atherosclerotic Cardiovascular Disease (ASCVD) in diabetes. 
This is a clinically meaningful problem, special for China, who has 114 million adults suffering from diabetes, by 
201313. However, the well-known ASCVD risk models, like Pooled Cohort Equations (PCE)14, are almost developed 
in American and/or European. Imaginably, when applying this PCE model in our cohort, we only get a moderate 
prediction performance, i.e. the area under the receiver operating characteristic curve (AUC) is 0.653. Next, we 
explore learning algorithms to combine this PCE model with our EHR data analysis, and our experimental results 
show higher prediction performance, and the AUC reaches to 0.723, improved by 10.7%. 
Methods 
Figure 1 shows our pipeline to develop a knowledge-enhanced chronic disease risk prediction model from regional 
EHR repositories. Except the knowledge part, as scoped by dashed lines, the pipeline has been introduced and 
validated in previous work15. In the pipeline, first is a clear problem definition, including the outcome and population 
of interest. Then, we will extract data from an EHR repository to build feature vectors, and due to the EHR data quality 
issues (to be discussed below), we possibly need to do data cleansing and missing data imputation. After that, feature 
selection would be applied to find the potential risk factors. Meanwhile, from well-established risk models, we can 
construct those known risk factors, and calculate the risk scores. Next, we will train prediction models using different 
algorithms, and in particular, we will introduce our knowledge-enhanced neural networks12. Finally, we will evaluate 
their prediction performance in term of AUC by train/test splitting. 
 
 
Figure 1. Pipeline to develop knowledge-enhanced chronic disease risk models from regional EHR repositories. 
 
Considering that we are facing a raw regional EHR repository, which consists of dozens of relational tables, this 
section will firstly introduce our EHR data schema, followed by pipeline components. 
EHR data schema.  Figure 2 shows a simplified data schema of our EHR repository. Its core is an Encounter table, 
with primary key of encounter id. Given an encounter, the information of who (patient id), where (organization id), 
when (commit time), and how (icd code, diagnosis and cost) are all recorded in the Encounter table. Also, the 
encounter type includes outpatient, inpatient, and follow-up visits etc. By foreign key of encounter id, other tables of 
Medication, LabTest, PhyExam, and FollowUp, etc. are associated. Demographic information is documented in the 
Patient table, with patient id mapping to the Encounter table. Since that’s a regional EHR repository, hospital names 
are documented in the Organization table, with organization id mapping to the Encounter table.  
  
It is remarkable that in China, the Steering Committee of Health Informatics led by Ministry of Health published the 
“Guideline for Building the Regional Health Information Platform based on Electronic Health Records” in 200916. 
This guideline describes a technical architecture, which includes a regional health information platform to exchange 
data among disparate healthcare information systems and a central EHR data repository that stores a longitudinal 
electronic record of patient health information generated by encounters in any care delivery setting. Since then, 
regional health information platforms have been developed and deployed almost in every city in China17, and the EHR 
repository described in this paper was one of them. In this respect, Figure 2 illustrates a common EHR data schema 
with Chinese characteristics while following international standards of HL7 CDA and IHE XDS. 
 
Figure 2. A simplified data schema of a regional EHR repository. 
Outcome definition.  ASCVD – defined as acute coronary syndromes (ACSs), a history of myocardial infarction 
(MI), stable or unstable angina, coronary or other arterial revascularization, stroke, transient ischemic attack, or 
peripheral arterial disease presumed to be of atherosclerotic origin – is the leading cause of morbidity and mortality 
for individuals with diabetes and is the largest contributor to the direct and indirect costs of diabetes18. A precision 
ASCVD risk prediction model in diabetes is critical for secondary prevention to improve outcome and reduce cost. 
The technical issue is how to identify which patients with/without ASCVD from the EHR data perspective. Generally, 
for registry data, it is often to use questionnaires to collect data, and e.g., via a checkbox, the ASCVD outcome is 
easily identified by clicking the checkbox or not. Differently, in EHR, patient data is collected in terms of encounters, 
and the ASCVD outcome identification needs to check the sequence of encounters for a given patient. As shown in 
Figure 2, the Encounter table has columns of icd_code and diagnosis. A design purpose of the icd_code column is to 
regularize the usage of international classification of diseases, i.e. ICD-10 code system19, but unfortunately, in real 
clinical settings, it exists null values and a lot invalidate values. By statistics, in the Encounter table, 6.7% is null, and 
among those non null values, only 54.7% can match the standard ICD-10 codes. The other column of diagnosis is 
designed for free text, and in our EHR repository, ASCVD is often not documented as a disease name, but a collection 
of disease names and even the subclasses. Worse, there are quite a few Chinese synonyms for every disease name in 
ASCVD, and for instance, stroke has at least 3 Chinese names, with dozens of subclasses. After consultation with 
local domain experts (esp. depending on their medical recording styles), we finally use fuzzy string match in the 
diagnosis column of the Encounter table, and find 334 distinct text values as identified for ASCVD. In the future work, 
we consider using advanced natural language processing technologies for a better medical concept learning20. 
Cohort definition.  The population of interest is a cohort of type 2 diabetes in adults (i.e. age >= 18) without ASCVD 
at the baseline. As shown in Figure 3, the cohort was constructed using de-identified patient records from a regional 
EHR repository. All medical records of diabetic patients treated in the index period between August 1st, 2012 and 
March 31st, 2016 (i.e., 44 months) were extracted. The index event was defined as a type 2 diabetes mellitus (T2DM) 
related diagnosis, prescription for T2DM medication, or both occurring at any time on or after August 1st, 2012 until 
the end of study follow-up. Included patients also had at least one medical visit within 360 days before the index 
  
period, and at least one T2DM outpatient visit from the index event to the end date – these two inclusive criteria were 
defined to ensure patients observable in the study period (special for a retrospective cohort extracted from EHR). 
Patients were excluded if they were diagnosed with gestational diabetes or type I diabetes, were under 18 years old, 
or if their gender was unknown. After applying these criteria, 89,558 T2DM patients were eligible for inclusion. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Inclusive criteria for the cohort definition from an EHR repository. 
Based on the 89,558 included patients, we furthermore divided them into three groups: (1) ASCVD diagnosis observed 
before T2DM diagnosis; (2) ASCVD diagnosis observed after T2DM diagnosis; (3) ASCVD diagnosis not observed. 
Figure 4 shows the counting number for each group, and finally, the population of interest stands for individuals in 
groups (2) and (3). The total number of our cohort is now 13,419 + 41,063 = 54,482, with an observation time window 
of 1 year before the index event (i.e. T2DM diagnosis firstly observed) to predict the risk of ASCVD. 
 
Figure 4. Time window and groups of included patients. 
Knowledge-based risk factor construction.  The Pooled Cohort Equations (PCE) has been recommended in 
ACC/AHA guidelines to estimate the 10-year risk of ASCVD among patients who have never had one of those 
ASCVD events in the past21. Undoubtedly, this knowledge could be leveraged as the seed for developing our localized 
ASCVD risk prediction model in diabetes. As mentioned in Introduction, the knowledge injection could have different 
implementation methods, and the straightforward one is to add knowledge-based risk factors and/or the calculated risk 
scores. Thus, we need to construct the knowledge-based risk factors from an EHR repository. 
In PCE, there are 9 risk factors: gender, age, race, total cholesterol (tc), high-density lipoproteins cholesterol (hdl-c), 
systolic blood pressure (sbp), receiving treatment for high blood pressure (hbp-treated), diabetes and smoker. 
Referring to our EHR data schema, gender and age are demographic information, as documented in the Patient table. 
The LabTest table has values of tc and hdl-c, while values of sbp and smoker need to query the FollowUp table. 
Although there is a PhyExam table, it documents patient image examination results but not including blood pressure 
values. In the Medication table, drug information has been documented, which provides the value of hbp-treated. 
Since that PCE were developed among Caucasian and African American men and women, the race in PCE is “African 
American” or “White or other”. Obviously, in our cohort, we set “White or other” for the race. Finally, we set “True” 
for the factor of diabetes, due to our cohort consisting of diabetic patients. 
Again, different from registry data, in an EHR data repository, we need to extract the features from sequences of 
encounters in the observation time window of 1 year before the index event (i.e. T2DM diagnosis firstly observed). 
Table 1 describes our extraction principles and the instance numbers. For the 54,482 patients as defined above, there 
is no missing value for gender and age. However, for the lab test of tc and hdl-c, only 12.8% and 8.7% have values. 
All patients in an EHR 
repository (N=3.6m) 
1+ any diabetes related 
diagnosis (N=190,431) 
Study period: 8/1/11à 
03/31/16 (N=149,774) 
Index event on or after 
8/1/12 (N=136,356) 
Age>= 18+ 
(N = 136,133) 
1+ visit within 1 year  
In pre-index period 
(N = 120,750) 
1+ T2DM outpatient visit 
from the index event to the 
end date (N = 89,558)	 
Gender = male or 
female (N = 136,085) 
  
By consultation with local domain experts, these low rates were not surprising, due to the poor patient adherence in 
China. Interestingly, our EHR data repository is from a tier II city in China, which is a pilot city of hierarchical medical 
systems. This reflects to our cohort with a high rate of follow up visits in community healthcare centers (CHCs), 
resulting in 45.6% has “sbp” values and 39.9% has “smoker” values – it might have null values for columns of 
systolic_bp and daily_smoking even if there was a follow up visit. Finally, for the treatment for high blood pressure, 
we map drug names into the high level drug classes, and find those drug names belonging to antihypertensive drug 
classes. We set “True” for this treatment feature, if an individual was observed having antihypertensive drug classes, 
else “False” – so, there is no missing value for hbp_treated. 
Table 1. Knowledge-based risk factor extraction principles in EHR and the statistics numbers. 
Risk factor EHR table EHR column Extraction principle Number 
Gender Patient gender / 54,482 
Age Patient birthday  (IndexEvent.commit_time – Patient.birthday)/365 54,482 
Total 
Cholesterol 
LabTest test_item_name 
test_value 
For test_item_name = ‘tc’ and  
0 <=(IndexEvent.commit_time – LabTest.commit_time) <= 365 
6,986 
HDL 
Cholesterol 
LabTest test_item_name 
test_value 
For test_item_name = ‘hdl-c’ and  
0 <= (IndexEvent.commit_time – LabTest.commit_time) <= 365 
4,722 
Systolic BP FollowUp systolic_bp 0 <= (IndexEvent.commit_time – FollowUp.commit_time) <= 365 24,827 
Treatment 
for HBP 
Medication drug_name For drug_name in Antihypertensive drug class and  
0 <= (IndexEvent.commit_time – Medication.commit_time) <= 365 
54,482 
Smoker FollowUp daily_smoking 0 <= (IndexEvent.commit_time – FollowUp.commit_time) <= 365 21,713 
 
Considering lab tests are value sensitive, local domain experts do not recommend us to do data imputation. Instead, 
they prefer to strictly build the instances. Thus, only 4,143 instances (without any null value) are remained. 
Knowledge-based risk score computation.  The PCE algorithm is publically available, consisting of cox proportional 
hazards regression models. We implement it to calculate the risk scores for each patient in our cohort. From the official 
report, PCE has been validated in the population in Caucasian American men and women with AUC of 0.75 and 0.80, 
while in African American men and women with AUC of 0.71 and 0.82, respectively14. The PCE model has also been 
evaluated in the Korean Heart Study22, and it reports AUC of 0.72. However, when applying it in our cohort, the AUC 
is only 0.653. By consultation with domain experts, there could be two reasons for the poor AUC in our cohort. First, 
PCE is a general ASCVD risk model where diabetes is one of the risk factors, while our cohort consists of diabetic 
patients. Second, the public PCE algorithm is used to predict 10-year risk, while the index period of our cohort has 
only 44 months. 
Data-driven feature construction.  The goal of our work is to develop an ASCVD risk prediction model in diabetes 
based on localized instances. Besides the above knowledge-based risk factors, we would like to leverage more data-
driven features to improve the model prediction performance and discovery new risk factors from data insights. 
Since that a regional EHR data repository consisting of longitudinal patient visits, the disease history for a given 
patient is traceable, and possibly, more reliable than the patient’s subjective answers to questionnaires. In this respect, 
we extract the ICD-10 codes from sequences of encounters to construct a feature vector of the disease history. By 
statistics, there are 27,258 distinct ICD-10 codes (e.g. E11.901 and E11.902) occurring in the Encounter table. Shall 
we build a vector of 27,258 features? No, because as mentioned above, the usage of ICD-10 is not as regularized as 
expected, resulting in an extremely sparse feature vector. 
One solution is using the 22 chapters of ICD-10 codes to define our data-driven feature vector, where each chapter 
represents a disease class (e.g. Chapter 4 is endocrine, nutritional and metabolic diseases, with blocks of E00-E90). 
The other solution is an extraction of the first 3-digit of an ICD-10 code, which represents a disease concept (e.g. E11 
is type 2 diabetes mellitus), and we extract 822 distinct 3-digit ICD-10 codes in our cohort. This vector with 822 
features will be next processed by feature selection. 
  
We do not involve more clinical measurements (i.e. lab tests and physical examinations) in our study, that’s because: 
(1) at model development phase, it’s hard to guarantee the population of interest having done all kinds of lab tests and 
physical examinations in a retrospective study of EHR; (2) at model application phase – since that our ultimate vision 
is to take the chronic disease risk prediction model into clinical practice – how to get all of these feature values? If we 
add more clinical measurements into the model, then it requires these tests or examinations to be done, which most 
possibly increases the economic burden (even, invasive hurt) of patients. 
Data-driven feature selection.  In machine learning, there are three main supervised feature selection strategies: 
filter, wrapper and embedded optimization. The methods of wrapper utilize a specific classifier (e.g. logistic 
regression) to select the subset of features that provides the best performance for a specific metric (e.g. AUC), while 
the methods of embedded optimization incorporate feature selection directly into the learning process of a model. 
Towards a fair comparison of learning models (with/without knowledge injection), we do not employ these model-
related feature selection methods in this paper, and instead, we use the model-independent filter methods. By 
calculating scores to represent the relevancy of a feature against the outcome, we select those mostly relevant features 
and filter others.  
Model learning.  In this study, we emphasize the knowledge injection to model learning process, and as mentioned 
in Introduction, we will explore three different injection methods. Formally, given an instance i (1<=i<=n), the 
outcome label is denoted as yi (1 for true, 0 for false), the data-driven feature vector is denoted as 𝑥" = (𝑓"&, … , 𝑓")), 
where each feature 𝑓+ (1<=j<=m) represents the value extracted from EHR (e.g. gender, age, the disease history), 
and the knowledge-based score vector is denoted as 𝑧" = (𝑠"&, … , 𝑠".), where each score 𝑠+ (1<=j<=k) represents the 
score calculated from a well-established risk model (e.g. PCE). The formalization of three injection methods is 
presented below, where l denotes the loss function that is typically cross entropy in classification tasks, 𝜃 represents 
the learning weights. 
• Knowledge injection to input features: Besides data-driven features (𝑓&, … , 𝑓)), we add the knowledge-based 
scores 𝑠&, … , 𝑠.  as the new features, together inputting to learning function 𝜎, where the objective function is 
defined as: 𝑎𝑟𝑔𝑚𝑖𝑛7 &8 𝑙(𝑦", 𝜎7(𝑥", 𝑧"))8";& . 
• Knowledge injection to objective functions: We leverage the calculated knowledge-based scores as the supervised 
signals for model learning, and there are two implantation methods. 
o Teacher-student networks (TSNNs)9: Given the jth (1<=j<=k) knowledge model, TSNNs are built 
iteratively, where the teacher network 𝜌  is obtained by projecting the student network 𝜎 𝑥" 	 to a 
knowledge-regularized subspace 𝑠"+, and the student network 𝜎 is updated to balance between emulating 
the teacher’s output 𝜌 𝑥"  and predicting the outcome labels yi. In particular, after convergence, both the 
teacher network and the student network could be used for prediction tasks. The objective function of 
teacher network is 𝑎𝑟𝑔𝑚𝑖𝑛7 &8 𝑙 𝜎7 𝑥" , 𝜌7 𝑥" + 𝜋@𝑙(𝑠"+, 𝜌7 𝑥" )8";&  and the objective function of 
student network is 𝑎𝑟𝑔𝑚𝑖𝑛7 &8 𝑙 𝜌7 𝑥" , 𝜎7 𝑥" + 𝜋A𝑙(𝑦", 𝜎7 𝑥" )8";& , where 𝜋@ and 𝜋A are weighting 
parameters for teacher and student networks respectively. 
o Knowledge-enhanced neural network (KENN)12: KENN will be trained end-to-end, in a simultaneous 
manner, with three network components. Given the jth (1<=j<=k) knowledge model, one is a knowledge 
representation network with target of the calculated score 𝑠"+, the other is a data representation network, 
and the output layers of these two upper networks will be joined side by side as the input for the final 
bottom network, with target of the outcome label yi. The objective function is defined as: 𝑎𝑟𝑔𝑚𝑖𝑛7 &8 1 − 𝜋 𝑙 𝑦", 𝜎7 𝑥" + 𝜋𝑙(𝑠"+, 𝜎7 𝑥" )8";& , where 𝜋 is the weighting parameter to adjust the 
relative knowledge importance. 
• Knowledge injection to output labels: The knowledge-based scores 𝑠&, … , 𝑠.  will be used for decision fusion11. 
Suppose 𝑠D = 𝜎 𝑥"  be the score from a data-driven learning model, the fusion function is denoted as  𝜔(𝑠"D, 𝑠"&, … , 𝑠".), and it could be as simple as majority voting, weighted average, or the meta-learning function 𝜑 
with an objective function as defined: 𝑎𝑟𝑔𝑚𝑖𝑛7 &8 𝑙(𝑦", 𝜑(𝑧"))8";& , where 𝑧" = (𝑠"D, 𝑠"&, … , 𝑠".). 
Model evaluation.  In this study, all models are trained on 80% of the cohort, remaining 20% for testing. The 
evaluation measure is AUC, considering that we aim at a practicable risk prediction model. 
  
Results 
For experiments, we start from a raw regional EHR repository including 190,431 diabetic patients, and as described 
in the section of cohort definition, only 54,482 patients were satisfied by the inclusive criterion. We employ PCE as 
the knowledge guidance, and due to the badly missing values of clinical measurements, we finally have 4,143 patients 
for building our ASCVD risk prediction model. Its Kaplan-Meier curve for survival analysis is shown in Figure 5, 
where 1,535 patients (37.1%) were observed by ASCVD diagnosis, while 2608 patients (62.9%) were censored. 
 
Figure 5. Kaplan-Meier curve for survival analysis. 
AUC comparison.  Directly using the PCE algorithm, we calculate the risk scores for our 4,143 patients, receiving 
AUC of 0.653 – that’s our baseline. To develop a more precision ASCVD risk model to well fit the local population, 
we adopt 8 different algorithms: (1) logistic regression LR, (2) LR extended with knowledge features LR-K, (3) neural 
network NN, (4) NN extended with knowledge features NN-K, (5) the teacher neural network TSNN-T, (6) the student 
neural network TSNN-S, (7) the knowledge-enhanced neural network KENN, and (8) the decision fusion DF using 
weighted average.  
For implementation, LR and LR-K are developed using the sklearn library23, while neural networks (for NN, NN-K, 
TSNN and KENN) are all developed using the keras library24. In particular, TSNN is developed with two iteratively 
trained neural networks, and we set the hyper-parameter of 𝜋@  as 0.653 (which reflects our PCE knowledge 
performance of AUC=0.653) while 𝜋A as 1. KENN is developed with three simultaneously trained neural networks, 
and similarly, we set the hyper-parameter of 𝜋 as 0.653. For each neural network building, we use 3 dense layers (i.e. 
fully connected layers), and to avoid overfitting, we stack a dropout (of 0.5) layer after each dense layer. These neural 
networks are all trained for 50 epochs, and considering the relatively small size of our instances, all hidden layers are 
set up with 8 cells and the batch size is 8.  
Table 2 shows the model comparison. All models are trained on 80% of the cohort (i.e. 3301 instances), remaining 
20% for testing (i.e. 842 instances). We have four experiments: (EX-1) using 7 known risk factors as defined in PCE, 
(EX-2) adding 22 chapters of ICD-10 codes, (EX-3) adding 822 distinct 3-digit ICD-10 codes, and (EX-4) adding 20 
highest scoring 3-digit ICD-10 codes as automatically selected by applying a univariate filter (the p-value from chi-
squared test). From the experimental results, we have the following findings. 
1. AUC is improved with more features involved, and for instance, LR has AUC of 0.690 for testing in EX-1, while 
LR has AUC of 0.715 for testing in EX-3, improved by 3.6% 
• However, facing the raw high dimension features (e.g. 822 features in EX-3), the performance is unacceptable 
(even worse than the baseline AUC 0.653), and after feature selection (i.e. EX-4), the performance becomes better 
2. Due to the limited training data size, NN is not promising, compared with LR, and worse, NN is more prone to 
be overfitting than LR – for every experiment, in training, NN has a higher AUC than LR  
3. The knowledge (PCE scoring) guidance is not strong, resulting a slight improvement of knowledge injection 
methods – for instance, neither LR-K significantly outperforms LR, nor NN-K outperforms NN 
  
4. Performance of TSNN-S and KENN are roughly the same, achieving the highest AUC in every experiment, and 
the final best model is using either TSNN-S or KENN with 7 known risk factors plus 20 selected data-driven 
features, with AUC of 0.723 – compared with the PCE baseline of 0.653, improved by 10.7% 
Table 2. AUC comparison of LR, LR-K, NN, NN-K, TSNN-T, TSNN-S, KENN and DF-WA. 
 EX-1: 7 known risk 
factors 
EX-2: 7 known risk factors 
+ 22 ICD chapters 
EX-3: 7 known risk factors + 
822 ICD 3-digit codes 
EX-4: 7 known risk factors + 20 ICD 
3-digit codes after feature selection 
Training Testing Training Testing Training Testing Training Testing 
LR 0.719 0.690 0.736 0.715 0.873 0.638 0.755 0.722 
LR-K 0.719 0.690 0.736 0.715 0.874 0.638 0.756 0.722 
NN 0.729 0.691 0.768 0.717 0.885 0.674 0.785 0.720 
NN-K 0.736 0.691 0.771 0.718 0.887 0.678 0.789 0.721 
TSNN-T 0.648 0.644 0.649 0.648 0.619 0.636 0.643 0.643 
TSNN-S 0.722 0.692 0.738 0.718 0.772 0.703 0.760 0.723 
KENN 0.714 0.692 0.737 0.719 0.774 0.702 0.751 0.723 
DF-WA 0.715 0.683 0.733 0.708 0.871 0.637 0.752 0.716 
 
Table 3. Univariate analysis and cox regression analysis. 
7	known	risk	factors	+	22	ICD	chapters	
	
7	known	risk	factors	+	20	ICD	codes	after	feature	selection	
	
Univariate		 Cox	regression	analysis	
	
Univariate		 Cox	regression	analysis	
Sig.	 Pearson	 Sig.	 Exp(B)	 95.0%	CI	for	Exp(B)	 Sig.	 Pearson	 Sig.	 Exp(B)	 95.0%	CI	for	Exp(B)	
Lower	 Upper	 Lower	 Upper	
gender	 .000	 .099	 .000	 1.235	 1.109	 1.375	 gender	 .000	 .099	 .000	 1.214	 1.091	 1.352	
age	 .000	 .313	 .000	 1.035	 1.030	 1.039	 age	 .000	 .313	 .000	 1.032	 1.027	 1.036	
tc	 .712	 .006	 .570	 .987	 .942	 1.033	 tc	 .712	 .006	 .736	 .992	 .947	 1.039	
hdl-c	 .001	 .052	 .435	 1.064	 .911	 1.243	 hdl-c	 .001	 .052	 .988	 1.001	 .858	 1.169	
sbp	 .000	 .135	 .000	 1.005	 1.003	 1.008	 sbp	 .000	 .135	 .001	 1.005	 1.002	 1.008	
treated	 .000	 .205	 .000	 .716	 .639	 .802	 treated	 .000	 .205	 .044	 .880	 .776	 .997	
smoker	 .211	 -.019	 .881	 .976	 .708	 1.345	 smoker	 .211	 -.019	 .669	 .932	 .677	 1.285	
c1	 .021	 .036	 .472	 .987	 .954	 1.022	 I10	 .000	 .225	 .000	 1.344	 1.189	 1.519	
c2	 .003	 .045	 .404	 1.006	 .992	 1.020	 E78	 .000	 .175	 .000	 1.344	 1.195	 1.512	
c3	 .028	 .034	 .613	 .993	 .969	 1.019	 H81	 .000	 .140	 .001	 1.306	 1.113	 1.532	
c4	 .000	 .119	 .983	 1.000	 .995	 1.005	 M54	 .000	 .110	 .569	 1.048	 .892	 1.231	
c5	 .015	 .038	 .020	 1.017	 1.003	 1.031	 H10	 .000	 .074	 .368	 1.105	 .889	 1.374	
c6	 .000	 .080	 .698	 1.007	 .974	 1.040	 J39	 .000	 .099	 .955	 1.004	 .859	 1.174	
c7	 .002	 .049	 .821	 .994	 .943	 1.048	 M81	 .000	 .097	 .956	 .995	 .820	 1.206	
c8	 .000	 .080	 .867	 1.003	 .967	 1.041	 K29	 .000	 .092	 .149	 1.104	 .965	 1.264	
c9	 .000	 .154	 .129	 1.006	 .998	 1.015	 M13	 .000	 .072	 .274	 1.130	 .907	 1.408	
c10	 .000	 .153	 .000	 1.040	 1.025	 1.056	 G47	 .000	 .088	 .027	 1.253	 1.026	 1.531	
c11	 .000	 .071	 .803	 .998	 .986	 1.011	 M25	 .000	 .109	 .082	 1.162	 .981	 1.376	
c12	 .248	 .018	 .228	 .983	 .956	 1.011	 J40	 .000	 .088	 .153	 1.146	 .951	 1.381	
c13	 .000	 .089	 .291	 1.005	 .996	 1.013	 J06	 .000	 .085	 .039	 1.155	 1.008	 1.324	
c14	 .024	 .035	 .092	 1.006	 .999	 1.013	 J00	 .000	 .108	 .929	 1.008	 .846	 1.201	
c15	 .016	 -.037	 .595	 .952	 .794	 1.141	 M24	 .000	 .076	 .171	 1.211	 .921	 1.592	
c16	 .278	 -.017	 .934	 .033	 .000	 .000	 G45	 .000	 .086	 .089	 1.268	 .964	 1.667	
c17	 .404	 -.013	 .509	 .642	 .172	 2.392	 J31	 .000	 .083	 .389	 1.085	 .901	 1.307	
c18	 .000	 .117	 .049	 1.018	 1.000	 1.035	 R53	 .000	 .076	 .219	 .870	 .696	 1.087	
c19	 .611	 .008	 .114	 .931	 .852	 1.017	 R09	 .000	 .125	 .042	 1.261	 1.009	 1.577	
c20	 .061	 .029	 .038	 1.346	 1.017	 1.780	 J45	 .000	 .070	 .017	 1.498	 1.076	 2.084	
c21	 .815	 .004	 .127	 .990	 .977	 1.003	 	       
 
  
Clinical findings.  Besides the prediction model development, we provide data insights to discover more risk factors 
for ASCVD in diabetes. Table 3 presents the univariate analysis and the cox regression analysis for models using 7 
known risk factors plus 22 ICD chapters (ref. EX-2), and using 7 known risk factors plus 20 ICD 3-digit codes after 
feature selection (ref. EX-4), respectively. For those features with statistical significance (p-value <= 0.05) in both 
analysis results, we highlight them in bold.  
For the univariate analysis, we use the Pearson correlation. For the 7 known risk factors, either in EX-2 or in EX-4, 
the Pearson correlation coefficients are the same. Except tc and smoker, other 5 risk factors have the statistical 
significance. Particularly, in EX-4, the 20 features of ICD 3-digit codes are selected because of their high relevancy 
against the outcome, and undoubtedly, they all have the statistical significance. However, for the 22 ICD chapters in 
EX-2, only c1-c11, c13-c15 and c18 have the statistical significance, where c15 (Pregnancy, childbirth and the 
puerperium) is the only protective factor. For c22 (Codes for special purposes), we have no observation for this ICD 
chapter in our cohort, so c22 has been ignored in Table 2. 
For the cox regression analysis, in both EX-2 and EX-4, hdl-c, tc and smoker are not statistically significant, while 
sbp-treated is the only protective factor with statistical significance. For the 22 ICD chapters in EX-2, only c5 (Mental 
and behavioral disorders), c10 (Diseases of the respiratory system), c18 (Symptoms, signs and abnormal clinical and 
laboratory findings, not elsewhere classified) and c20 (External causes of morbidity and mortality) have the statistical 
significance, while for the selected 20 ICD codes in EX-4, only I10 (Essential (primary) hypertension), E78 (Disorders 
of lipoprotein metabolism and other lipidemias), H81 (Disorders of vestibular function), G47 (Sleep disorders), J06 
(Acute upper respiratory infections of multiple and unspecified sites), R09 (Other symptoms and signs involving the 
circulatory and respiratory system) and J45 (Asthma) have the statistical significance. 
Discussion 
To echo the question in Introduction, we have confidence to answer “YES”, esp., after our exploration on developing 
a knowledge-enhanced ASCVD risk model in diabetes from a raw EHR repository. However, from this case study, 
we also realize it deserves more investigations towards a more practicable risk model for clinical decision support. 
First, we admit our learning data size is poorly small in this study. Facing the original 190,431 diabetic patients, why 
do we finally only get 4,143 instances? We have to own this to the data quality of our EHR repository. On the one 
hand, the standardized usage of medical code systems (e.g. ICD-10) is not satisfactory in developing countries (e.g. 
China), and to address this problem, we are planning to learn high-level medical concepts from free text20 in our future 
work. On the other hand, the regular collection of clinical measurements (e.g. lab tests) is seriously problematic, 
mostly due to the low quality of patient adherence. Although regularly evaluating the fasting lipid profile has been 
recommended in diabetic guidelines18, only 10% diabetic patients have fasting lipid profiles in our EHR repository. 
Similar ratio even for HbA1c, despite it recommends to test HbA1c within 3 months for diabetic patients18. Besides, 
by consulting local clinicians, we were told that portable tests/examinations such as blood glucose and blood pressure, 
most possibly, totally not documented in the hospital information system (neither existing in the laboratory 
information system). That’s why we only use the disease history as data-driven features in this study. Actually, using 
machine learning methods for EHR data analysis, related work mostly takes the disease history and medication history 
into account3,4, disregarding the clinical measurements. The exception is using EHR data in the ICU (intensive care 
unit)5, which clinical measurements are always continuously observable. In our study, to avoid the strong correlation 
between the disease history and the medication history, we finally extract the disease history as data-driven features. 
Second, the knowledge guidance signal is a bit weak. Our motivation is using knowledge guidance to greatly improve 
the prediction performance, but our experimental results show a slight improvement. Besides, more advanced methods 
of knowledge injection to objective functions are desirable. Our implementation of TSNN/KENN requires the 
instance-level knowledge labels (i.e. the calculated risk score for each instance), while the structure-level knowledge 
injection10 is more attractive. In clinical scenario, it might be directly projecting the logical rules (e.g. clinical 
guidelines for treatment recommendation) or the arithmetic formulas (e.g. logistic/cox regression for risk prediction) 
into the neural network learning. 
Conclusion 
With the popularity of building regional healthcare information platform2,15, EHR repositories have stored (billions 
of) clinical documents for (millions of) patients in the past decade (in terms of a tier II city in China). Towards the 
meaningful use of EHR, this paper proposes to develop the knowledge-enhanced chronic disease risk prediction 
models from regional EHR repositories. The knowledge enhancement is meant to leverage those well-established 
  
(inter-)national risk models for guidance in the EHR data learning process, and chronic diseases fit well with 
longitudinal patient visits documented in regional EHR repositories.  
As a case study, we present our experiments on developing an ASCVD risk model in diabetes, from the cohort 
definition and feature construction, to the knowledge injection and model evaluation. Specially, we implement 
different algorithms for knowledge injection into input features, objective functions and output labels. The 
experimental results demonstrate the prediction performance improvement of our models, and by consultation with 
domain experts, our models also provide data insights for clinical findings. This paper exploits the way for knowledge 
learning symbiosis in healthcare, and for future work, we are planning to validate our methods on more EHR 
repositories to address different clinical problems.  
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